A murine model of neurofibromatosis type 1 tibial pseudarthrosis featuring proliferative fibrous tissue and osteoclast-like cells

Osteoclasts in neurofibromatosis type 1 display enhanced resorption capacity, aberrant morphology, and resistance to serum deprivation

(2010) Eetu Heervä et al.   BONE

Local low-dose lovastatin delivery improves the bone-healing defect caused by Nf1 loss of function in osteoblasts

(2010) Weixi Wang et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Myoblast sensitivity and fibroblast insensitivity to osteogenic conversion by BMP-2 correlates with the expression of Bmpr-1a

(2009) Renjing Liu et al.   BMC MUSCULOSKELETAL DISORDERS

Mechanisms in the pathogenesis of malignant tumours in neurofibromatosis type 1

(2009) Hilde Brems et al.   LANCET ONCOLOGY

Modelling neurofibromatosis type 1 tibial dysplasia and its treatment with lovastatin

(2008) Mateusz Kolanczyk et al.   BMC Medicine

Biologic Characteristics of Fibrous Hamartoma from Congenital Pseudarthrosis of the Tibia Associated with Neurofibromatosis Type 1

(2008) Tae-Joon Cho et al.   JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME

Use of Cre-adenovirus and CAR transgenic mice for efficient deletion of genes in post-thymic T cells

(2008) Yuanyuan Zha et al.   JOURNAL OF IMMUNOLOGICAL METHODS

Models of tibial fracture healing in normal and Nf1‐deficient mice

(2008) Aaron Schindeler et al.   JOURNAL OF ORTHOPAEDIC RESEARCH

Modeling bone morphogenetic protein and bisphosphonate combination therapy in wild-type andNf1 haploinsufficient mice

(2007) Aaron Schindeler et al.   JOURNAL OF ORTHOPAEDIC RESEARCH